|Aleafia Health Successfully Completes TSX Review and Announces||Diogenes of Sinope||11/28/22 12:46 PM|
|If I was buying and flipping I could||FUNMAN||11/09/22 9:34 AM|
|Aleafia Health Announces Achieving Major Profitability Milestone Ahead||Diogenes of Sinope||11/09/22 9:19 AM|
|Good luck.||FUNMAN||11/07/22 9:58 PM|
|Thank you.||Diogenes of Sinope||11/02/22 12:16 PM|
|Thanks FM.||Diogenes of Sinope||11/02/22 12:15 PM|
|Aleafia Health to Announce Fiscal Year 2023 Second||FUNMAN||11/02/22 11:02 AM|
|Aleafia Health Expands Sunday Market House of Brands||FUNMAN||11/01/22 9:52 AM|
|I am holding and buying more. Imo it||happyglass||10/27/22 9:06 PM|
|Haven’t checked in for a while.||Diogenes of Sinope||10/27/22 1:14 PM|
|Why isn't there a chart for half of||happyglass||10/05/22 2:44 PM|
|Aleafia Health Announces Results of Annual General Meeting||FUNMAN||09/29/22 11:30 AM|
|Why are we still stuck at a shit price!!!!!||Chrism0000||09/05/22 10:27 AM|
|Aleafia Health Announces $12.0 Million Total Net Revenue||FUNMAN||08/11/22 10:35 PM|
|Unifor members to elect new national president in||FUNMAN||08/09/22 5:05 PM|
|Aleafia Health to Announce Fiscal Year 2023 First||FUNMAN||08/04/22 11:35 AM|
|Sadly, the “turn” happened at around $1.40.||Diogenes of Sinope||08/01/22 3:38 PM|
|TURNING!!! INTO ONE BIG!!!!!!!!! PIECE OF SH#$!!!!!!!!!!!!!!!!!!||Chrism0000||08/01/22 3:33 PM|
|Because this is a Canadian company.||happyglass||07/22/22 1:33 PM|
|Why is it when all pot stocks go||Chrism0000||07/20/22 10:22 AM|
|I just got some very encouraging news at||happyglass||07/05/22 12:01 PM|
|https://www.globenewswire.com/news-release/2022/06/02/2455686/0/en/Aleafia-Healt||Diogenes of Sinope||06/03/22 6:50 AM|
|My whole family (except me lol) have them||happyglass||05/24/22 10:06 PM|
|Does anyone what’s the O/S diluted shares at||macman95835||05/24/22 7:16 PM|
|Aleafia Health Continues Ascent in Adult-Use Cannabis||Diogenes of Sinope||05/24/22 8:25 AM|
|I just saw this. beggars can't be choosers.||FUNMAN||05/15/22 5:28 PM|
|What do you think about this turn of||happyglass||05/13/22 12:15 PM|
|Aleafia Health Announces Agreement to Amend Convertible Debentures||Diogenes of Sinope||05/12/22 3:39 PM|
|Thank you!||happyglass||04/28/22 6:41 PM|
|Aleafia Health Provides Further Update on its Convertible Debt||FUNMAN||04/28/22 10:29 AM|
|They are not suffocating that badly, I just||happyglass||04/21/22 12:45 PM|
|They are suffocating--->>>Aleafia Health Provides Further Update on||FUNMAN||04/12/22 10:54 AM|
|This girl gets relief from the products Aleafia||happyglass||04/05/22 12:13 PM|
|https://financialpost.com/globe-newswire/aleafia-health-provides-further-upd||Diogenes of Sinope||03/29/22 8:18 AM|
|Thank you for the info||happyglass||03/28/22 12:52 PM|
|Aleafia Health gains market share in adult use||FUNMAN||03/25/22 9:30 AM|
|Nothing much||FUNMAN||03/25/22 9:30 AM|
|So in your best guess, what do you foresee?||Chrism0000||03/23/22 9:26 AM|
|Aleafia Health Provides Further Update on its Convertible Debt||FUNMAN||03/23/22 9:21 AM|
|I really hope they get their act together.||Chrism0000||02/24/22 7:41 PM|
|LOL Chrism0000 Thursday, February 24, 2022 12:43:06 PM||FUNMAN||02/24/22 3:32 PM|
|Over the next 2 years, this company will||Chrism0000||02/24/22 12:43 PM|
|Unifor president Jerry Dias goes on medical leave||FUNMAN||02/17/22 2:08 PM|
|Excellent info. Thank you for posting. I||happyglass||02/16/22 11:01 AM|
|Earnings Call Transcript: Aleafia Health, Inc. (ALEAF)||FUNMAN||02/15/22 3:20 PM|
|I am sitting on a substantial position I||FUNMAN||02/15/22 1:12 PM|
|This is actually very good considering Canopy’s net||happyglass||02/15/22 10:45 AM|
|See RED and blue highlights||FUNMAN||02/15/22 9:37 AM|
|Aleafia Health Reports Q4 2021 Financial Results||Diogenes of Sinope||02/15/22 4:15 AM|
|Notable earnings before Tuesday's open||FUNMAN||02/14/22 10:23 AM|
At our Aleafia Farms, a federally licensed ACMPR facility in Scugog, Ont., we produce standardized, pesticide-free medical cannabis for patients in need, resulting from years of expertise in its commercial cultivation. Our management team’s decades of experience in law enforcement, science and technology and corporate governance ensures the safety and security of this facility.
We currently operate a 7,000-square-foot state-of-the-art indoor hydroponic facility that is contained within 76 acres of developable land interned for a planned multi-phase expansion in the near future.
With our recent strategic acquisition of Canabo, which currently operates 25 clinics nationwide and is rapidly expanding, our registered patients exceed 50,000 and comprise approximately a quarter of the current estimated total Canadian patient base. To satisfy the demand of our current and future patients, Aleafia recently successfully completed a round of financing and has begun the process of planning our first 150,000-square-foot phase-one expansion of a state-of-the-art grow facility. This is part of a master plan to build up to 1.2 million square feet on our existing property.
Aleafia is firmly committed to helping patients find effective treatments for chronic and serious conditions through the use of prescription cannabinoid therapy. We are uniquely positioned to create a vertically integrated model from seed to patient while expanding our grow capacity to produce standardized pesticide-free medical cannabis products for patients in need.
Dedicated to increasing the understanding of medical cannabis’ many benefits, Aleafia Science deploys Big Data to influence patient care. Our mission, providing the most advanced doctor and patient support, will be data based, deriving from in-depth research and development strategies on the latest industry findings. This will provide further insight into cannabis’ many uses, ensuring appropriate and safe patient consumption. Using Canabo Medical Clinic’s vast historical data, Aleafia Science’s new clinical products will achieve the highest possible efficiency rates.
With extensive medical potential, Cannabinoids like THC and CBD, the key chemical components in cannabis, are extremely effective in treating many medical conditions and provide a wide range of symptom relief.
For example, medical cannabis can be used to treat both acute and chronic pain caused by arthritis and fibromyalgia. It helps reduce muscle spasms caused by multiple sclerosis, Tourette’s syndrome, and Parkinson’s. Medical cannabis has long been used as an appetite stimulant for cancer patients undergoing chemotherapy, and new research shows its promise in helping to treat PTSD, opioid addiction, sleep disorders, gastrointestinal diseases, and epilepsy.
While much medical cannabis research has been carried out, more is necessary. Aleafia Science will partner with other cannabis scientists to advance important breakthroughs and determine how to better propagate the medical properties of cannabis plants. We look forward to discovering new ways to engineer strains that most effectively treat particular medical conditions, ensuring our patients are guided and monitored based on the most up-to-date research.
With medical cannabis research advancing globally, Aleafia Science keeps the Aleafia brand at the forefront of innovation by studying cannabis’ effectiveness on opioid dependence, medical treatment and patient recovery. As new studies are conducted, Aleafia Health will evolve and adapt with the newest scientific discoveries.
Download our Investor Presentation and learn more about why you should invest in Aleafia Health: https://aleafiainc.com/wp-content/uploads/2018/04/aleafia-investor-presentation-april-30-2018.pdf
Connect on Social Media: